Astellas Institute for Regenerative Medicine clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration Start date pushed from Jul 13, 2018 to Jan 30, 2019
- Minor: DEVOTE · About the Safety of a Single ASP2020 Eye Injection and if it Helps · Vision Loss From Stargardt-type Eye Conditions Start date pushed from Aug 10, 2026 to Aug 14, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 1 |
Get alerts when Astellas Institute for Regenerative Medicine's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.